Life Sciences
Gene therapy pioneer Shiela Mikhail is stepping down as CEO at AskBio
Sheila Mikhail, a pioneer and thought leader in genetics, is stepping down as CEO of AskBio, a company she co-founded and later sold to global giant Bayer…
RESEARCH TRIANGLE PARK – Sheila Mikhail, a pioneer and thought leader in genetics and gene therapy, is stepping down as CEO of AskBio, a company she co-founded and later sold to global giant Bayer AG in 2020 for some $4 billion.
Mikhail will be replaced as CEO on March 11 by Gustavo Pesquin. His most recent position was chief commercial officer at Amneal Pharmaceuticals.
AskBio (full name Asklepios BioPharmaceutical) announced the changes Thursday.
Mikhail will remain a member of the AskBio board and also will have a part-time role as adviser/co-founder, the company said.
“In her new role, Mikhail will continue to support the strategic direction and growth of AskBio. She will also continue to support Columbus Children’s Foundation (CCF) in its development of gene therapies for ultra-rare diseases,” the company said.
RTP genetics firm AskBio to pursue more gene therapies in new partnership
The post Gene therapy pioneer Shiela Mikhail is stepping down as CEO at AskBio first appeared on WRAL TechWire.
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….